Deconstructing the Potency and Cell-Line Selectivity of Membranolytic Anticancer Peptides.


Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
17 07 2023
Historique:
revised: 07 03 2023
received: 26 01 2023
medline: 18 7 2023
pubmed: 30 3 2023
entrez: 29 3 2023
Statut: ppublish

Résumé

Current cancer treatments damage healthy cells and tissues, causing short-term and long-term side effects. New treatments are desired that show greater selectivity toward cancer cells and evade the common mechanisms of multidrug resistance. Membranolytic anticancer peptides (mACPs) hold promise against cancer and multidrug resistance. Amphipathicity, hydrophobicity, and net charge of mACPs participate in their respective interactions with cell membranes and their overall inhibition of cancer cells. To support the design of cell-line selective mACPs, we investigated the relationships that amino acid composition, physicochemical properties, sequence motifs, and sequence homology could have with their potency and selectivity towards several healthy and cancer cell lines. Sequence length and net charge are known to affect the selectivity of mACPs between cancer and healthy cell lines. Our study reveals that increasing the net charge or flexibility (i. e., small and aliphatic residues) influences their selectivity between cancer cell lines with comparable lipid compositions.

Identifiants

pubmed: 36988008
doi: 10.1002/cbic.202300058
doi:

Substances chimiques

Peptides 0
Amino Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202300058

Informations de copyright

© 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH.

Références

G. De Castro, A. Awada, Curr. Opin. Oncol. 2006, 18, 307-315.
National Cancer Institute, Types of Cancer Treatment, 2015.
B. A. Parsons, S. Evans, M. P. Wright, Maturitas 2009, 63, 323-328.
R. W. M. Vernooij, R. G. H. M. Cremers, H. Jansen, D. M. Somford, L. A. Kiemeney, G. van Andel, B. P. Wijsman, M. B. Busstra, R. J. A. van Moorselaar, E. M. Wijnen, F. J. Pos, M. C. C. M. Hulshof, P. Hamberg, F. van den Berkmortel, C. A. Hulsbergen-van de Kaa, G. J. L. H. van Leenders, J. J. Fütterer, I. M. van Oort, K. K. H. Aben, Urol. Oncol.: Semin. Orig. Investig. 2020, 38, 735e17-735e25.
K. D. Miller, L. Nogueira, A. B. Mariotto, J. H. Rowland, K. R. Yabroff, C. M. Alfano, A. Jemal, J. L. Kramer, R. L. Siegel, Ca-Cancer J. Clin. 2019, 69, 363-385.
M. Nikolaou, A. Pavlopoulou, A. G. Georgakilas, E. Kyrodimos, Clin. Exp. Metastasis 2018, 35, 309-318.
B. Colmegna, L. Morosi, M. D'Incalci, in Mech. Drug Resist. Cancer Ther. (Eds.: M. Mandalà, E. Romano), Springer International Publishing, Cham, 2018, pp. 1-12.
D. W. Hoskin, A. Ramamoorthy, Biochim. Biophys. Acta Biomembr. 2008, 1778, 357-375.
T. Samec, J. Boulos, S. Gilmore, A. Hazelton, A. Alexander-Bryant, Mater. Today Bio 2022, 14, 100248.
S. Riedl, B. Rinner, M. Asslaber, H. Schaider, S. Walzer, A. Novak, K. Lohner, D. Zweytick, Biochim. Biophys. Acta Biomembr. 2011, 1808, 2638-2645.
D. Gaspar, A. Salomé Veiga, M. A. R. B. Castanho, Front. Microbiol. 2013, 4, 1-16.
G. Gabernet, A. T. Müller, J. A. Hiss, G. Schneider, MedChemComm 2016, 7, 2232-2245.
N. Papo, Y. Shai, Cell. Mol. Life Sci. 2005, 62, 784-790.
J. S. Mader, D. W. Hoskin, Expert Opin. Invest. Drugs 2006, 15, 933-946.
Y. Wang, D. Li, H. Shi, Y. Wen, L. Yang, N. Xu, X. Chen, X. Chen, P. Chen, J. Li, H. Deng, C. Wang, G. Xie, S. Huang, Y. Mao, L. Chen, X. Zhao, Y. Wei, Clin. Cancer Res. 2009, 15, 6901-6911.
D. Wu, Y. Gao, Y. Qi, L. Chen, Y. Ma, Y. Li, Cancer Lett. 2014, 351, 13-22.
N. Nishida, H. Yano, T. Nishida, T. Kamura, M. Kojiro, Vasc. Health Risk Manage. 2006, 2, 213-219.
C. Guo, K. Liu, H. Luo, H. Chen, Y. Zheng, S. Sun, Q. Zhang, L. Huang, PLoS One 2011, 6, e17734.
T. Harayama, H. Riezman, Nat. Rev. Mol. Cell Biol. 2018, 19, 281-296.
L. M. Butler, Y. Perone, J. Dehairs, L. E. Lupien, V. de Laat, A. Talebi, M. Loda, W. B. Kinlaw, J. V. Swinnen, Adv. Drug Delivery Rev. 2020, 159, 245-293.
K. R. Kampen, J. Membr. Biol. 2011, 242, 69-74.
M. R. Felício, O. N. Silva, S. Gonçalves, N. C. Santos, O. L. Franco, Front. Chem. 2017, 5.
F. Schweizer, Eur. J. Pharmacol. 2009, 625, 190-194.
F. Harris, S. R. Dennison, J. Singh, D. A. Phoenix, Med. Res. Rev. 2013, 33, 190-234.
A. L. Hilchie, D. W. Hoskin, M. R. Power Coombs, Adv. Exp. Med. Biol. 2019, 1117, 131-147.
W. Szlasa, J. Bioenerg. Biomembr. 2020, 52, 321-342.
S. Dennison, M. Whittaker, F. Harris, D. Phoenix, Curr. Protein Pept. Sci. 2006, 7, 487-499.
S. R. Dennison, F. Harris, T. Bhatt, J. Singh, D. A. Phoenix, Mol. Cell. Biochem. 2010, 333, 129-135.
D. Takahashi, S. K. Shukla, O. Prakash, G. Zhang, Biochimie 2010, 92, 1236-1241.
A. L. Hilchie, A. J. Sharon, E. F. Haney, D. W. Hoskin, M. B. Bally, O. L. Franco, J. A. Corcoran, R. E. W. Hancock, Biochim. Biophys. Acta Biomembr. 2016, 1858, 3195-3204.
Q.-Z. Yang, C. Wang, L. Lang, Y. Zhou, H. Wang, D.-J. Shang, Arch. Pharmacal Res. 2013, 36, 1302-1310.
M. Pirtskhalava, A. Gabrielian, P. Cruz, H. L. Griggs, R. B. Squires, D. E. Hurt, M. Grigolava, M. Chubinidze, G. Gogoladze, B. Vishnepolsky, V. Alekseev, A. Rosenthal, M. Tartakovsky, Nucleic Acids Res. 2016, 44, D1104-D1112, https://dbaasp.org/.
R. B. Badisa, S. F. Darling-Reed, P. Joseph, J. S. Cooperwood, L. M. Latinwo, C. B. Goodman, Anticancer Res. 2009, 29, 2993-2996.
D. L. Shapiro, L. L. Nardone, S. A. Rooney, E. K. Motoyama, J. L. Munoz, Biochim. Biophys. Acta 1978, 530, 197-207.
R. J. Mason, M. C. Williams, Biochim. Biophys. Acta Lipids Lipid Metab. 1980, 617, 36-50.
M. Naito, I. Kudo, Y. Nakagawa, K. Waku, H. Nojiri, M. Saito, K. Inoue, J. Biochem. (Tokyo) 1987, 102, 155-162.
M. Maccarrone, W. E. Nieuwenhuizen, H. F. Dullens, M. V. Catani, G. Melino, G. A. Veldink, J. F. Vliegenthart, A. Finazzo Agrò, Eur. J. Biochem. 1996, 241, 297-302.
A. Llorente, T. Skotland, T. Sylvänne, D. Kauhanen, T. Róg, A. Orłowski, I. Vattulainen, K. Ekroos, K. Sandvig, Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2013, 1831, 1302-1309.
J. Bestard-Escalas, A. Maimó-Barceló, D. H. Lopez, R. Reigada, F. Guardiola-Serrano, J. Ramos-Vivas, T. Hornemann, T. Okazaki, G. Barceló-Coblijn, Cancers 2020, 12, 1293.
T. L. Bailey, M. Boden, F. A. Buske, M. Frith, C. E. Grant, L. Clementi, J. Ren, W. W. Li, W. S. Noble, Nucleic Acids Res. 2009, 37, W202-208, https://meme-suite.org/.
Y. Huang, Q. Feng, Q. Yan, X. Hao, Y. Chen, Mini-Rev. Med. Chem. 2015, 15, 73-81.
S. Zalba, T. L. M. Hagen, Cancer Treat. Rev. 2017, 52, 48-57.
T. Rivel, C. Ramseyer, S. Yesylevskyy, Sci. Rep. 2019, 9, 1-14.
A. Tyagi, P. Kapoor, R. Kumar, K. Chaudhary, A. Gautam, G. P. S. Raghava, Sci. Rep. 2013, 3, 2984.
G. Gabernet, D. Gautschi, A. T. Müller, C. S. Neuhaus, L. Armbrecht, P. S. Dittrich, J. A. Hiss, G. Schneider, Sci. Rep. 2019, 9, 11282.
P. Agrawal, D. Bhagat, M. Mahalwal, N. Sharma, G. P. S. Raghava, Briefings Bioinf. 2021, 22, 1-12.
R. Ge, G. Feng, X. Jing, R. Zhang, P. Wang, Front. Genet. 2020, 11, DOI 10.3389/fgene.2020.00760.
L. S. Vermeer, Y. Lan, V. Abbate, E. Ruh, T. T. Bui, L. J. Wilkinson, T. Kanno, E. Jumagulova, J. Kozlowska, J. Patel, C. A. McIntyre, W. C. Yam, G. Siu, R. A. Atkinson, J. K. W. Lam, S. S. Bansal, A. F. Drake, G. H. Mitchell, A. J. Mason, J. Biol. Chem. 2012, 287, 34120-34133.
Y. Huang, X. Wang, H. Wang, Y. Liu, Y. Chen, Mol. Cancer Ther. 2011, 10, 416-426.
I. Zelezetsky, A. Tossi, Biochim. Biophys. Acta Biomembr. 2006, 1758, 1436-1449.
N. Pathak, R. Salas-Auvert, G. Ruche, M. Janna, D. McCarthy, R. G. Harrison, Proteins Struct. Funct. Bioinf. 1995, 22, 182-186.
A. Tossi, L. Sandri, A. Giangaspero, Pept. Sci. 2000, 55, 4-30.
Z. Jiang, A. I. Vasil, J. D. Hale, R. E. W. Hancock, M. L. Vasil, R. S. Hodges, Biopolym. Pept. Sci. Sect. 2008, 90, 369-383.
C. A. Rohl, W. Fiori, R. L. Baldwin, Proc. Natl. Acad. Sci. USA 1999, 96, 3682-3687.
E. J. H. Bartels, D. Dekker, M. Amiche, Front. Pharmacol. 2019, 10, 1-11.
C. D. Santos, S. Hamadat, K. L. Saux, C. Newton, M. Mazouni, L. Zargarian, M. Miro-Padovani, P. Zadigue, J. Delbé, Y. Hamma-Kourbali, M. Amiche, PLoS One 2017, 12, e0182926.
G. W. Caldwell, Z. Yan, W. Lang, J. A. Masucci, Curr. Top. Med. Chem. 2012, 12, 1282-1290.
N. Xiao, D.-S. Cao, M.-F. Zhu, Q.-S. Xu, Bioinformatics 2015, 31, 1857-1859.
T. L. Bailey, C. Elkan, Proc. Int. Conf. Intell. Syst. Mol. Biol. 1994, 2, 28-36.
A. T. Müller, G. Gabernet, J. A. Hiss, G. Schneider, Bioinformatics 2017, 33, 2753-2755.
D. Osorio, P. Rondón-Villarreal, R. Torres, R J. 2015, 7, 4.
R Core Team, R. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria., 2020, http://www.r-project.org.
RStudio Team, RStudio: Integrated Development Environment for R. RStudio, PBC, Boston, MA, 2019, http://www.rstudio.com.
M. P. J. Van der Loo, R J. 2014, 6, 111-122.
R. C. Edgar, BMC Bioinf. 2004, 5, 1-19.
S. Kumar, G. Stecher, M. Li, C. Knyaz, Mol. Biol. Evol. 2018, 35, 1-8.
A. M. Waterhouse, J. B. Procter, D. M. A. Martin, M. Clamp, G. J. Barton, Bioinformatics 2009, 25, 1189-1191.

Auteurs

Cristina Martinez-Hernandez (C)

Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Unidad de Genómica Avanzada, Laboratorio Nacional de Genómica para la Biodiversidad (Langebio), Irapuato, Guanajuato, 36824, Mexico.

Mariana Del Carmen Aguilera-Puga (M)

Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Unidad de Genómica Avanzada, Laboratorio Nacional de Genómica para la Biodiversidad (Langebio), Irapuato, Guanajuato, 36824, Mexico.
CINVESTAV-IPN, Unidad Irapuato, Departamento de Biotecnología y Bioquímica, Irapuato, Guanajuato, 36824, Mexico.

Fabien Plisson (F)

Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Unidad de Genómica Avanzada, Laboratorio Nacional de Genómica para la Biodiversidad (Langebio), Irapuato, Guanajuato, 36824, Mexico.
CINVESTAV-IPN, Unidad Irapuato, Departamento de Biotecnología y Bioquímica, Irapuato, Guanajuato, 36824, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH